Anbio Biotechnology Payments of Stock Issuance Costs
Anbio Biotechnology (NNNN) reported Payments of Stock Issuance Costs of $282.55 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-04-07
| Period end | Payments of Stock Issuance Costs 12 month |
|---|---|
| 2025-12-31 | $282.55K 20-F · filed 2026-04-07 |
| 2024-12-31 | $344.61K 20-F · filed 2026-04-07 |
| 2023-12-31 | $42.84K 20-F · filed 2026-04-07 |